Concepedia

Carol Pretswell

CP

3

Publications

183

Citations

3

H-Index

2021

Active since

Affiliations

Synexus (United Kingdom)(Current)

Aberdeen Royal Infirmary

National Institute for Health Research

University of Essex

Betsi Cadwaladr University Health Board

Carol Pretswell is an author at Synexus (United Kingdom) specializing in vaccine development, vaccinology, and vaccine surveillance.

Top concepts

Publications per year

2021–2022

3

Publications

3

The Adjuvanted Recombinant Zoster Vaccine Confers Long-Term Protection Against Herpes Zoster: Interim Results of an Extension Study of the Pivotal Phase 3 Clinical Trials ZOE-50 and ZOE-70

Céline Boutry, Andrew Hastie, Javier Díez‐Domingo et al. · Clinical Infectious Diseases · 2021 · 90 citations · Full text

Safety and Efficacy of the NVX-CoV2373 Coronavirus Disease 2019 Vaccine at Completion of the Placebo-Controlled Phase of a Randomized Controlled Trial

Paul T. Heath, Eva Galiza, D. N. Baxter et al. · Clinical Infectious Diseases · 2022 · 72 citations · Full text

Efficacy of the NVX-CoV2373 Covid-19 Vaccine Against the B.1.1.7 Variant

Paul T. Heath, Eva Galiza, D. N. Baxter et al. · 2021 · 21 citations · Full text

, , +13

Rows per page

1–3 of 3